PT-141
Acts on the brain to support desire and sexual function.
iThe essentials in 10 seconds
- Acts on the brain (melanocortin system) — not on blood vessels
- Increases desire and sexual response, in both women and men
- Subcutaneous injection, about 1 to 2 h before the desired moment
- On-demand use — possible transient nausea and blood pressure changes
IWhat is PT-141?
PT-141 (Bremelanotide) is a melanocortin receptor agonist: it acts on the central nervous system, on desire circuits, unlike conventional treatments that act on blood circulation. It is the 1st molecule of this type approved for female sexual desire disorder.
Regulated medication, with possible adverse effects (nausea, flushing, blood pressure). Reserved for prescription and medical monitoring, without uncontrolled cardiovascular risk factors.
IIThe benefits
Enhances sexual desire by acting on the brain's pleasure circuits.
Works on the brain, whereas conventional treatments act on blood flow.
Documented response in interest / sexual desire disorder (approved in Western countries).
May contribute to erectile response and desire as a complement to other approaches.
Effect within an hour after injection — on-demand use.
Combines with management of underlying causes (hormones, stress, medications).
IIIRecommendations & how to use
Route: subcutaneous injection (abdomen) · Timing: about 1 to 2 h before the desired moment · On-demand use, not daily · Storage: refrigerated (2–8 °C).
Avoid driving if nausea occurs.
| Dosage | Euro | Dollar | Dirham |
|---|---|---|---|
| 10 mg | 55 € | 60 $ | 600 DH |
Indicative exchange rates — final price confirmed during consultation.
IVThe two protocols
Goal: improve desire and sexual response on an as-needed basis.
Monitoring: tolerability (nausea, blood pressure), perceived effect.
Goal: durably treat the causes of the disorder, as a complement to on-demand treatment.
Comprehensive approach: hormones, psychological factors, relationship, medications.
VProtocol rules
- Contextualize: desire remains largely psychological and relational
- Sleep and stress management
- Hormonal workup in parallel
- Note effect and tolerability
- Store vials in the refrigerator
- Never self-medicate: prescription medication
- Do not exceed the prescribed dose
- Driving if nausea after injection
- Excess alcohol on the day of use
- Uncontrolled hypertension or cardiovascular disease, pregnancy: contraindication
VIYour journey in 3 steps
Assessment (hormones, blood pressure, medications), injection training, protocol provided.
Injection 1 to 2 h before the desired moment, monitoring tolerability.
Efficacy, tolerability, decision on continuation and background treatment.